Hanlon Investment Management Inc. trimmed its position in Johnson & Johnson (NYSE:JNJ – Free Report) by 20.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,651 shares of the company’s stock after selling 430 shares during the period. Hanlon Investment Management Inc.’s […]